Therapeutic antibodies are now the major class of successful protein drugs with many more in development to target a variety of major diseases. An important and desirable biological activity of most ...

Promega Corporation has announced the introduction of a novel bioluminescent assay for the quantification of Fc effector function of antibody-based molecules in the development and manufacture of ...

MADISON, Wis.--(BUSINESS WIRE)--Drug developers have a new bioluminescent tool to characterize how potential pharmaceuticals behave in biologically relevant systems. A new primary cell bioassay from ...

Antibody drugs such as monoclonal antibodies (mAb), bispecific antibodies, antibody-drug conjugates (ADCs), and nanobodies garnered increased interest in research and development circles. Sino ...

NEW YORK CITY, NEW YORK, USA, January 31, 2024 /EINPresswire / -- Creative Bioarray, a distinguished pioneer in the biotechnology field, has developed avant-garde ADCC, CDC, and ADCP assays catered ...

The epidermal growth factor receptor (EGFR) is overexpressed in colorectal cancer (CRC), and is correlated with poor prognosis, making it an attractive target for monoclonal antibody (mAb) therapy. A ...

NEW YORK CITY, NEW YORK, USA, January 31, 2024 /EINPresswire.com/ -- Creative Bioarray, a distinguished pioneer in the biotechnology field, has developed avant-garde ...